ADRENOCORTICAL CARCINOMA (ACC)
Clinical trials for ADRENOCORTICAL CARCINOMA (ACC) explained in plain language.
Never miss a new study
Get alerted when new ADRENOCORTICAL CARCINOMA (ACC) trials appear
Sign up with your email to follow new studies for ADRENOCORTICAL CARCINOMA (ACC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation approach tested for Tough-to-Treat adrenal cancer
Disease control Recruiting nowThis study is testing if giving radiation therapy before surgery is safe for people whose adrenal cancer has returned. It will enroll 32 adults with recurrent adrenal cancer that can be removed with surgery. The main goal is to find the highest safe dose of radiation to give befo…
Matched conditions: ADRENOCORTICAL CARCINOMA (ACC)
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 05:21 UTC
-
New immune drug targets liver tumors in advanced cancer trial
Disease control Recruiting nowThis study is testing whether adding a new immune-stimulating drug called PDS01ADC to a specialized liver cancer treatment can better control advanced cancers that have spread to the liver. The treatment involves surgically placing a pump that delivers chemotherapy directly to th…
Matched conditions: ADRENOCORTICAL CARCINOMA (ACC)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC